格列吡嗪

glipizide
29094-61-9

￥20000 5 kg 起订

山东更新日期：2018-12-27

威海迪素制药有限公司

非会员

联系人：赵亚旗

手机：15065164308 拨打

邮箱：zhao.yaqi@disha.com.cn

产品详情:

中文名称：: 格列吡嗪

英文名称：: glipizide

CAS号：: 29094-61-9

纯度规格：: 99%

产品类别：: 原料药中间体

我司优势生产格列吡嗪；

glipizide with GMP ，CEP，DMF CAS：29094-61-9

Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.
Originally available in 1984, it is marketed by Pfizer under the brand name Glucotrol in the USA, where Pfizer sells Glucotrol in doses of 5 and 10 milligrams and Glucotrol XL (an extended release form of glipizide) in doses of 2.5, 5, and 10 milligrams.

格列吡嗪；glipizide；CAS：29094-61-9 ；格列甲嗪；

公司简介

Established in May, 2005, Weihai Disu Pharmaceutical Co., Ltd., is a subsidiary of Disha Pharmaceutical Group, and a national high-tech enterprise. Relying on the R&D strength of DiSha Pharmaceutical Group, Weihai DiSu Pharmaceutical Co.,Ltd has eight professional institutes which provide product development, process optimization and other technical services. With outstanding strength in scientific research and technological innovation ,it is a leader in pharmaceutical intermediates, veterinary drug, marine biological products and so on. The company's products strictly enforce the standa

成立日期	(19年)
注册资本	40000万
员工人数	500人以上
年营业额	￥ 1亿以上
经营模式	工厂
主营行业	医药中间体,原料药,天然化学药,解热镇痛药,心血管系统用药